Electromed

Rising Home Healthcare Trends Will Unlock New Market Opportunity

AnalystHighTarget

Not Invested

Community Contributor

Published

26 Jul 25

AnalystHighTarget's Fair Value

US$38.00

36.3% undervalued

10 Sep

US$24.19

19.2%

-2.3%

19.2%

-2.3%

You can edit this narrative until Jul 26 9:14 PM. Then, changes will post as Updates.

Author's Valuation

US$38

36.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$38

36.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.44%

Medical Equipment revenue growth rate

0.39%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.37%

Calculation

US$14.79m

Earnings '28

25.46x

PE Ratio '28

US$376.53m

Market Cap '28

US$376.53m

Market Cap '28

8.03m

No. shares '28

US$46.89

Share Price '28

US$46.89 Share Price '28

Discounted to 2025 @ 7.39% p.a.

US$37.85

Fair Value '25